SUBSTANTIAL RISE IN SPARTEINE METABOLIC RATIO DURING HALOPERIDOL TREATMENT

被引：54

作者：

GRAM, LF

DEBRUYNE, D

CAILLARD, V

BOULENGER, JP

LACOTTE, J

MOULIN, M

ZARIFIAN, E

机构：

[1] UNIV CAEN,HOSP CTR,CTR PSYCHIAT ESQUIROL,F-14032 CAEN,FRANCE

[2] UNIV CAEN,HOSP CTR,PHARMACOL LAB,F-14032 CAEN,FRANCE

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb05362.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：272 / 275

页数：4

共 22 条

[11]

GRAM LF, 1972, BRIT MED J, V1, P165

[12]

GRAM LF, 1984, FRONTIERS BIOCH PHAR, P399

[13]

INABA T, 1985, DRUG METAB DISPOS, V13, P443

[14]

JORGENSEN A, 1986, PROG DRUG METAB, V9, P111

[15] PHARMACOKINETICS AND METABOLISM OF QUINIDINE IN EXTENSIVE AND POOR METABOLIZERS OF SPARTEINE [J].

MIKUS, G ;

HA, HR ;

VOZEH, S ;

ZEKORN, C ;

FOLLATH, F ;

EICHELBAUM, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) :69-72

[16] SERUM LEVEL MONITORING AND THERAPEUTIC EFFECT OF HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS [J].

MOULIN, MA ;

DAVY, JP ;

DEBRUYNE, D ;

ANDERSSON, JC ;

BIGOT, MC ;

CAMSONNE, R ;

POILPRE, E .

PSYCHOPHARMACOLOGY, 1982, 76 (04) :346-350

[17] INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY TRICYCLIC ANTI-DEPRESSANTS AND OTHER DRUGS [J].

OTTON, SV ;

INABA, T ;

KALOW, W .

LIFE SCIENCES, 1983, 32 (07) :795-800

[18]

OTTON SV, 1988, DRUG METAB DISPOS, V16, P15

[19] COMPETITIVE-INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY BETA-ADRENOCEPTOR ANTAGONISTS AND OTHER CARDIOVASCULAR DRUGS [J].

OTTON, SV ;

INABA, T ;

KALOW, W .

LIFE SCIENCES, 1984, 34 (01) :73-80

[20] QUINIDINE AND THE IDENTIFICATION OF DRUGS WHOSE ELIMINATION IS IMPAIRED IN SUBJECTS CLASSIFIED AS POOR METABOLIZERS OF DEBRISOQUINE [J].

SPEIRS, CJ ;

MURRAY, S ;

BOOBIS, AR ;

SEDDON, CE ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (06) :739-743

← 1 2 3 →